Skip to content
10-Q

Quarterly Report

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB

0001299130-25-000102

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 300.08M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $284.6M
Short Term Investments Q1 2025 · Dec 31, 2024 $334.56M
Current Liabilities Q1 2025 · Mar 31, 2025 $66.6M
Current Liabilities Q1 2025 · Dec 31, 2024 $66.3M
Total Liabilities Q1 2025 · Mar 31, 2025 $769.15M
Total Liabilities Q1 2025 · Dec 31, 2024 $753.85M
Current Assets Q1 2025 · Mar 31, 2025 $444.92M
Current Assets Q1 2025 · Dec 31, 2024 $495.68M
Total Assets Q1 2025 · Mar 31, 2025 $860.79M
Total Assets Q1 2025 · Dec 31, 2024 $1.26B
Cash And Equivalents Q1 2025 · Dec 31, 2024 $55.37M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $76.65M
Shares Diluted Q1 2025 · Mar 31, 2024 269.58M sh
Capex Q1 2025 · Mar 31, 2024 $3.88M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$75.68M
Stockholders Equity Q1 2025 · Mar 31, 2024 $649.02M
Stockholders Equity Q1 2025 · Dec 31, 2023 $701.3M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.29
Eps Basic Q1 2025 · Mar 31, 2024 −$0.29
Sga Expense Q1 2025 · Mar 31, 2024 $43.75M
Rd Expense Q1 2025 · Mar 31, 2024 $43.46M
Net Income Q1 2025 · Mar 31, 2024 −$78.18M
Operating Income Q1 2025 · Mar 31, 2024 −$81.36M
Gross Profit Q1 2025 · Mar 31, 2024 $11.28M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $27.53M
Revenue Q1 2025 · Mar 31, 2024 $38.81M